{"id":"W3095171343","doi":"10.1016/s0959-8049(20)31128-x","title":"Theranostic 64Cu-DOTHA2-PSMA for metastatic prostate cancer treatment, a preclinical study","year":2020,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Radioligand; Biodistribution; Prostate cancer; Glutamate carboxypeptidase II; Medicine; In vivo; Cancer research; Radionuclide therapy; Oncology; Pharmacology; Nuclear medicine; Cancer; Internal medicine; Biology; Receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004669765,0.0007593847,0.0007035053,0.0002827616,0.0003868848,0.0005799502,0.0005474581,0.0006179473,0.002554283],"category_scores_gemma":[0.0002255088,0.0003082214,0.0004874824,0.0002319994,0.0004311594,0.0004984586,0.0002392264,0.001293318,0.0005638416],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005393184,"about_ca_system_score_gemma":0.001014978,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002758757,"about_ca_topic_score_gemma":0.004004998,"domain_scores_codex":[0.999848,0.00003444787,0.000003406504,0.00002990566,0.0000287507,0.00005543137],"domain_scores_gemma":[0.9999267,0.00001258249,0.00001260742,0.000008218211,0.00001133802,0.00002851775],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.003169935,0.005467771,0.0005097079,0.0006844958,0.0001845131,0.0003213048,0.0002220694,0.002809775,0.9427868,0.001153242,0.00338471,0.03930567],"study_design_scores_gemma":[0.003326961,0.0623583,0.006453558,0.0001071503,0.0008251039,0.002030519,0.000228608,0.00938545,0.8676717,0.0007898857,0.04674751,0.00007519878],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9664134,0.01764765,0.005259998,0.001094808,0.0002645641,0.0004726325,0.0004410535,0.0002585541,0.008147459],"genre_scores_gemma":[0.9827862,0.008409807,0.002179193,0.0002743478,0.00007412121,0.0001881091,0.0004305338,0.00004603256,0.005611748],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002758757,"threshold_uncertainty_score":0.008544862,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1731371315537489,"score_gpt":0.4549716049300678,"score_spread":0.2818344733763188,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}